158 related articles for article (PubMed ID: 38454392)
41. Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil.
Goren A; Roberts C; Victor TW
Expert Rev Vaccines; 2014 Jan; 13(1):175-84. PubMed ID: 24308584
[TBL] [Abstract][Full Text] [Related]
42. Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China.
Jiang Y; Zhang X; Lv Q; Qi J; Guo X; Wei Q; Liao Z; Lin Z; Gu J
Hum Vaccin Immunother; 2019; 15(5):1100-1105. PubMed ID: 30689509
[TBL] [Abstract][Full Text] [Related]
43. Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake.
Gatwood J; Shuvo S; Hohmeier KC; Hagemann T; Chiu CY; Tong R; Ramachandran S
Vaccine; 2020 Jul; 38(35):5607-5617. PubMed ID: 32654903
[TBL] [Abstract][Full Text] [Related]
44. A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.
Campling J; Vyse A; Liu HH; Wright H; Slack M; Reinert RR; Drayson M; Richter A; Singh D; Barlow G; Kassianos G; Ellsbury G
Expert Rev Vaccines; 2023; 22(1):785-800. PubMed ID: 37694398
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital.
Smith JG; Metzger NL
J Manag Care Pharm; 2011 Nov; 17(9):701-8. PubMed ID: 22050395
[TBL] [Abstract][Full Text] [Related]
46. Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies.
Bar-Zeev N; Swarthout TD; Everett DB; Alaerts M; Msefula J; Brown C; Bilima S; Mallewa J; King C; von Gottberg A; Verani JR; Whitney CG; Mwansambo C; Gordon SB; Cunliffe NA; French N; Heyderman RS;
Lancet Glob Health; 2021 Jul; 9(7):e989-e998. PubMed ID: 34143997
[TBL] [Abstract][Full Text] [Related]
47. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
48. Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.
Loubet P; Verger P; Abitbol V; Peyrin-Biroulet L; Launay O
Dig Liver Dis; 2018 Jun; 50(6):563-567. PubMed ID: 29371056
[TBL] [Abstract][Full Text] [Related]
49. Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension.
Wang CS; Doma R; Westbrook AL; Johnson J; Anderson EJ; Greenbaum LA; Rana SA; George RP; Garro R; Khanna-Farber A; Escoffery C; Bednarczyk RA
Am J Kidney Dis; 2023 Jan; 81(1):25-35.e1. PubMed ID: 35750280
[TBL] [Abstract][Full Text] [Related]
50. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
[TBL] [Abstract][Full Text] [Related]
51. Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice.
Siriwardena AN
Postgrad Med J; 1999 Apr; 75(882):208-12. PubMed ID: 10715759
[TBL] [Abstract][Full Text] [Related]
52. Human Papillomavirus (HPV) Vaccine Coverage and Confidence in Italy: A Nationwide Cross-Sectional Study, the OBVIOUS Project.
Montalti M; Salussolia A; Capodici A; Scognamiglio F; Di Valerio Z; La Fauci G; Soldà G; Fantini MP; Odone A; Costantino C; Leask J; Larson HJ; Lenzi J; Gori D;
Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400170
[TBL] [Abstract][Full Text] [Related]
53. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
Taitel M; Cohen E; Duncan I; Pegus C
Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
[TBL] [Abstract][Full Text] [Related]
54. Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.
Maertzdorf KM; Rietman ML; Lambooij MS; Verschuren WMM; Picavet HSJ
Vaccine; 2023 Feb; 41(6):1254-1264. PubMed ID: 36639273
[TBL] [Abstract][Full Text] [Related]
55. Attitudes, motivators, and barriers toward influenza vaccination for children: a study from a conflict-ridden country.
Ahmed WS; Halboup AM; Alshargabi A; Al-Mohamadi A; Al-Ashbat YK; Al-Jamei S
Confl Health; 2024 Apr; 18(1):26. PubMed ID: 38566200
[TBL] [Abstract][Full Text] [Related]
56. Using classification and regression tree analysis to explore parental influenza vaccine decisions.
Lama Y; Hancock GR; Freimuth VS; Jamison AM; Quinn SC
Vaccine; 2020 Jan; 38(5):1032-1039. PubMed ID: 31806534
[TBL] [Abstract][Full Text] [Related]
57. Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States.
McLaughlin JM; Swerdlow DL; Khan F; Will O; Curry A; Snow V; Isturiz RE; Jodar L
Hum Vaccin Immunother; 2019; 15(4):841-849. PubMed ID: 30676236
[TBL] [Abstract][Full Text] [Related]
58. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
[TBL] [Abstract][Full Text] [Related]
59. Impact of innovative immunization strategy on PCV13 vaccination coverage among children under 5 years in Weifang city, China: A retrospective study.
Wang CP; Lin YT; Du YZ; Zhang T; Wang YY; Wang YJ; Wang JC; Xu RY; Wang ZS; Wang Y; Feng LZ
Vaccine; 2024 Feb; 42(5):1136-1144. PubMed ID: 38267332
[TBL] [Abstract][Full Text] [Related]
60. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
